People · Operator
Named in public records as an officer, director or promoter · active 2014–2017 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Tendyne Holdings, Inc. | — | Biotechnology | Series B | $67.5M | $992.2M | 2014 |
| Vdyne, Inc. | — | Biotechnology | Series A | $33.0M | $234.0M | 2017 |
Edward W. Malouf at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Edward W. Malouf on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Greg Pearl | 2 | 2 |
| Martin J. Waters | 1 | 9 |
| David McIntyre | 1 | 5 |
| Joseph M. Smith | 1 | 3 |
| Kemal Schankereli | 1 | 2 |
| Jeffrey Franco | 1 | 2 |
| Joseph W. Smith | 1 | 1 |
| Edward Mercaldo | 1 | 1 |
| Robert Vidlund | 1 | 1 |
| Jean-Raymond Boulle II | 1 | 1 |
| Lucian Lozonschi | 1 | 1 |
| Kemal W. Schankereli | 1 | 1 |
| David W. McIntyre | 1 | 1 |
| Greg W. Pearl | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.